baber/WOPTO huggingface dataset:
Patent AU-2019325522-A1 (AU)
Title: Smart inhaler device with automated dose delivery, measurement, and management
Inventor: HATAMIAN MEHDI
IPC: A24F47/00
Filed: 2019-08-21
Abstract: A smart inhaler device includes: a flow pathway comprising a cartridge receptacle that is able to house a cartridge, flow meter, pump, and vaporizer; a wireless communication module; and at least one sensor that captures identifying information related to the cartridge. A method of providing a measured dose using a smart inhaler device includes: enabling dosing; measuring a provided dose; and disabling dosing. A smart inhaler system includes: a smart inhaler device; a user device; and a server.
Patent AU-2019339510-A1 (AU)
Title: Lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereof
Inventor: DOCHERTY JOHN
IPC: A24B15/18
Filed: 2019-09-13
Abstract: Aspects described herein relate to lipophilic active agent infused tobacco leaves and/or tobacco materials and methods of use thereof. More particularly, aspects described herein relate to tobacco leaves and/or tobacco materials infused with lipophilic active agents that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes.
Patent AU-2019358599-A1 (AU)
Title: Protein for treatment of inflammatory diseases
Inventor: SATHE DHANANJAY
IPC: A61K38/16
Filed: 2019-09-14
Abstract: The present invention relates to a lectin for use in the treatment, reduction in progression and curing of inflammation in a subject in need thereof. Pharmaceutical compositions comprising said lectin are also described. The lectin may comprise an amino acid sequence having sequence of SEQ ID NO: 1 or at least 60% homology to SEQ ID NO: 1.
Patent AU-2019383003-A1 (AU)
Title: Combination of chemotherapy with recombinant S. rolfsii lectin
Inventor: SATHE DHANANJAY
IPC: A61K31/513
Filed: 2019-11-18
Abstract: The present invention relates to the combination chemotherapy with recombinant lectin protein. The invention specifically relates to the cytotoxic effect of recombinant lectin protein having amino acid sequence of SEQ ID NO: 1 in combination with other therapeutic agents, wherein the other therapeutic agents are anti-cancer agents. The combinations are highly synergistic and efficacious against several cancers.
Patent AU-2019440195-A1 (AU)
Title: A building truss, system, and construction method
Inventor: AITKEN KIM ELIZABETH
IPC: E04C3/02
Filed: 2019-04-11
Abstract: A building truss comprising a structural floor element (10), a vertical support on each side of the structural floor element (11), rafters spanning the vertical supports (12), a structural horizontal tie (13) which interconnects the rafters, and a roof peak (14) on the horizontal tie (13). A building is constructed by erecting multiple trusses (1) parallel to each other in sequence in a longitudinal direction spanning one gable end to the opposed gable end. Each building truss defines the full room and roof spaces and provides the required structural strength. Each truss (1) defines a 2D envelope; the floor element spanning in the horizontal direction, vertical supports for the vertical direction, and a roof assembly joining the two vertical supports. Each truss is unitary and constructing the multiple trusses parallel to each other provides a 3D structural building envelope.
Patent AU-2019466071-A1 (AU)
Title: Magnetoelastic torque sensor assembly for reducing magnetic error due to harmonics
Inventor: VEILLETTE JEAN-FRANCOIS
IPC: G01L3/10
Filed: 2019-09-13
Abstract: A torque sensor assembly including a shaft configured to receive an applied torque. The shaft includes at least one region being magnetoelastic and configured to generate a magnetic field in response to the applied torque. A plurality of sensors, circumferentially positioned around the at least one region, configured to generate a plurality of signals that are indicative of the magnetic field. Each of the plurality of signals includes multiple harmonic components. A controller is connected with the plurality of sensors and being configured to receive the plurality of signals and determine (i) an average of the plurality of signals in order to cancel at least one of the harmonic components of the multiple harmonic components for each of the plurality of signals, and (ii) a magnitude of the applied torque based on the average of the plurality of signals.
Patent AU-2020201848-A1 (AU)
Title: Pharmacological treatment of cognitive impairment
Inventor: GARNER CRAIG C
IPC: A61K31/55
Filed: 2020-03-13
Abstract: Abstract Methods for treating an individual to improve cognitive function are provided. In the subject methods, an effective amount of a noncompetitive GABAA ionophore blocker is administered to the individual, resulting in an improvement in cognitive function of the host. The subject methods find use in a variety of different applications.
Patent AU-2020202755-A1 (AU)
Title: Delivery of mRNA for the augmentation of proteins and enzymes in human genetic diseases
Inventor: GUILD BRAYDON CHARLES
IPC: C07H21/02
Filed: 2020-04-24
Abstract: Disclosed herein are compositions and methods of modulating the expression of gene or the production of a protein by transfecting target cells with nucleic acids. The compositions disclosed herein demonstrate a high transfection efficacy and are capable of ameliorating diseases associated with protein or enzyme deficiencies.
Patent AU-2020204345-A1 (AU)
Title: Force transferring member for use in a tool
Inventor: REINHARDT PAUL ANDREW
IPC: E21B33/128
Filed: 2020-06-29
Abstract: A tool (100) for use in a wellbore comprising a seal assembly (112), a collet member 
(114), and a cone member (110). The seal assembly (112) is coupled to the collet 
member (114) and in engagement with the cone member (110). A force transferring 
member is movable from a first state that prevents relative movement between the 
seal assembly and the cone member, to a second state where the seal assembly is 
movable relative to the cone member.
o) co 
CN 
co 
CN 
CN 
C) 
co 
CCN 
0C
Patent AU-2020204558-A1 (AU)
Title: Compositions and methods of providing thyroid hormone or analogs thereof
Inventor: TENGLER MARK
IPC: A61K9/28
Filed: 2020-07-08
Abstract: The present invention includes a pharmaceutical composition, and methods of making and 
using, a pharmaceutical composition comprising one or more thyroid hormone(s) or analogs 
thereof, wherein a first portion of thyroid hormone(s) is formulated for immediate release and 
a second portion of thyroid hormone(s) is formulated of modified release, e.g., by forming a 
drug-resin particle with an ion exchange resin.
Patent AU-2020208994-A1 (AU)
Title: Bed exit monitoring
Inventor: MCANENA STEVEN
IPC: G08B21/04
Filed: 2020-01-15
Abstract: A bed exit detection device (100) according to an embodiment of the present invention is mounted to a privacy rail (11) provided in the vicinity of a bed (10) to be monitored. The device (100) comprises a thermographic sensor (130) and a range sensor (40). The thermographic sensor comprises an array of sensing elements operable to generate an output value matrix from the output signals of each individual sensing element.The device (100) is also provided with a processing unit (150) operable to process the output value matrix of the thermographic sensor (130) and the distance output by the range sensor (140) so as to determine the position of a bed occupant and thereby (10) determine the likelihood of a bed exit event.
Patent AU-2020218267-A1 (AU)
Title: TYK2 pseudokinase ligands
Inventor: MOHAN RAJU
IPC: C07D401/12
Filed: 2020-02-07
Abstract: Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
Patent AU-2020221290-A1 (AU)
Title: Clubroot resistant brassica plants
Inventor: NGUYEN THI NINH THUAN
IPC: C12Q1/68
Filed: 2020-02-14
Abstract: The invention provides low erucic, clubroot resistant Brassica plants, plant material and seeds, characterized in that these products harbor a specific CrS clubroot resistance locus in their genome. Tools are also provided which allow detection of the CrS clubroot resistance locus.
Patent AU-2020223584-A1 (AU)
Title: Bipolar plate, cell frame, cell stack, and redox flow battery
Inventor: KANNO TAKASHI
IPC: H01M8/0258
Filed: 2020-02-03
Abstract: This bipolar plate faces electrodes of a redox flow battery and is provided with an introducing passage and a discharging passage of an electrolyte, wherein one among the introducing passage and the discharging passage is a groove-like flow passage formed in a surface and the other is a pipe-like flow passage formed inside the surface, the bipolar plate comprising a communication hole which communicates with the pipe-like passage from the surface.
Patent AU-2020237205-A1 (AU)
Title: Antimicrobial fiber blends
Inventor: FINCK THOMAS JAD
IPC: D06M15/05
Filed: 2020-03-12
Abstract: Antimicrobial fiber blends including a chitosan-based fiber are disclosed. The fiber blends also include other fibers such as organic fibers, synthetic fibers, or a combination thereof. Yarns and textiles formed from the fiber blends and articles formed from the textiles are also disclosed.
Patent AU-2020241434-A1 (AU)
Title: System and apparatus for conditioning water and regnererating ion exchange resin
Inventor: MOSHER STEVEN
IPC: B01J49/50
Filed: 2020-03-13
Abstract: A system and method for regeneration of an ion exchange material employed in a water softening or conditioning system. The method includes the step of contacting the ion exchange material with an aqueous process fluid that includes a compound having as set forth in General Formula I to yield a regenerated ion exchange material with at least one target material removed. The target material includes at least one of the following: metal ions such as those that have been extracted from a source of hard water, ionically soluble organic compounds, active water borne pathogens. During the contacting step, at least a portion of the target material associated with the ion exchange material is removed from association with the ion exchange material. After removal from association with the ion exchange material, the target material is retained in the process fluid and conveyed to a suitable recovery and/or removal source.
Patent AU-2020242810-A1 (AU)
Title: Work shoe
Inventor: FRANK WILHELM
IPC: A43C15/16
Filed: 2020-01-30
Abstract: The invention relates to a work shoe, in particular for use in leveling work and/or trowel work and/or for lawn aeration. The work shoe is designed such that a foot of a wearer can be introduced in the shoe via an opening and the work shoe is provided with downwardly projecting spaced-apart elements.
Patent AU-2020256255-A1 (AU)
Title: Luggage system
Inventor: Nichols Steve Charles
IPC: A45C5/14
Filed: 2020-04-03
Abstract: A suitcase having a base and a lid where the lid may be rotatable about a hinge from a closed configuration to an open configuration and may be secured, via one or more latching assemblies is disclosed. The lid may comprise an upper shell, and the base may comprise a lower shell. The upper shell and the lower shell may be seamlessly formed to create a water resistant and/or waterproof suitcase. The suitcase may have an extendable trolley handle assembly that is externally attached to the base of the suitcase using a plurality of mounting clips. The trolley handle assembly may comprise a pair of extrusion assemblies that are connected to the base of the suitcase and connected to each other by a grip. The suitcase may also have a removably secured interior liner.
Patent AU-2020257131-A1 (AU)
Title: Crystalline FGFR4 inhibitor compound and uses thereof
Inventor: MONIZ GEORGE
IPC: A61K31/505
Filed: 2020-10-22
Abstract: CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF 
Abstract 
A number of crystalline forms of N-(2-((6-(3-(2,6-dichloro-3,5-dimethoxyphenyl)-1
methylureido)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)acrylamide are provided.  
These include a crystalline free base form, a crystalline monohydrochloride salt form, a 
crystalline dihydrochloride salt form, and a crystalline ethanesulfonate salt form. Methods of 
making and using crystalline compounds are also provided.
Patent AU-2020257163-A1 (AU)
Title: Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
Inventor: MALONEY DAVID J
IPC: A61K31/427
Filed: 2020-10-23
Abstract: OF THE DISCLOSURE 
Provided is a compound of formula (I) 
w 
W Ar1-U (i 
x 
V 
(I), 
in which Ar', R', U, V, W, X, and p are as described herein. Also provided are methods of 
using a compound of formula (I), including a method of treating cancer, a method of treating 
a patient with cancer cells resistant to an anti-cancer agent, and a method of inhibiting lactate 
dehydrogenase A (LDHA) and/ or lactate dehydrogenase B (LDHB) activity in a cell.
Patent AU-2020268878-A1 (AU)
Title: Compositions and methods for the treatment of leukodystrophy and whole animal and cellular models for identifying efficacious agents for treatment of the same
Inventor: ALMAD AKSHATA
IPC: C12N15/113
Filed: 2020-05-11
Abstract: Compositions and methods for the treatment of leukodystrophy, particularly, H-ABC are disclosed.
Patent AU-2020270520-A1 (AU)
Title: Substituted tricyclic compounds as fgfr inhibitors
Inventor: WU LIANGXING
IPC: A61P35/00
Filed: 2020-11-18
Abstract: The present invention relates to tricyclic compounds, and pharmaceutical 
compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in 
the treatment of FGFR-associated diseases such as cancer.
Patent AU-2020285476-A1 (AU)
Title: System and method for limiting mobile phone use by drivers
Inventor: MEHTA DILIP JEHTALA
IPC: H04W48/04
Filed: 2020-05-29
Abstract: A system for limiting use of an electronic mobile device by a driver of a vehicle is provided. The system includes a mobile device controller for removable connection with a vehicle and an electronic mobile device for wireless communicating with the mobile device controller. The electronic mobile device includes an application installed thereon and an electronic mobile device processor programmed to execute one or more instructions of the application stored in the electronic mobile device. The instructions include temporarily disabling radio frequency signal transmission of the electronic mobile device, requesting an input via the one or more electronic mobile devices that satisfies a predetermined criterion, receiving the input that satisfies the predetermined criterion from at least one of the one or more electronic mobile devices, and restoring radio frequency signal transmission of the at least one of the one or more electronic mobile devices.
Patent AU-2020286250-A1 (AU)
Title: Asset transfer method and apparatus, and electronic device
Inventor: HU DANQING
IPC: G06Q40/02
Filed: 2020-12-09
Abstract: ASSET TRANSFER METHOD AND APPARATUS, AND ELECTRONIC 
DEVICE 
ABSTRACT 
A computer-implemented method, non-transitory computer readable medium and computer implemented 
system for transferring assets. In one aspect, the computer-implemented method comprises: detecting, by a 
blockchain node in a blockchain, an asset transfer request related to transfer an asset to a blockchain member 
associated with the blockchain, wherein the asset is of a specified blockchain asset type and is issued by a 
specified anchor in the blockchain, wherein the specified anchor is configured to convert an equivalent off
chain asset to an asset of the specified blockchain asset type; determining, by the blockchain node and based 
on recorded data comprising different maximum trusted asset limits configured by the blockchain member 
for different anchors in the blockchain, that a maximum trusted asset limit is not configured by the 
blockchain member for the specified anchor and that corresponds to the specified blockchain asset type, 
wherein the maximum trusted asset limit for a given anchor and given blockchain asset type indicates the 
blockchain member's trust in the given anchor for converting the maximum trusted asset limit of assets of 
the given blockchain asset type into an off-chain asset; and in response to determining by the blockchain 
node that the maximum trusted asset limit is not configured for the specified anchor and that corresponds 
to the specified blockchain asset type: prohibiting application of the asset transfer request to the asset by 
the blockchain node.
Patent AU-2020289846-A1 (AU)
Title: Restricted immunoglobulin heavy chain mice
Inventor: MACDONALD LYNN
IPC: A01K67/027
Filed: 2020-12-18
Abstract: Mice having a restricted immunoglobulin heavy chain locus are provided, wherein the locus 
is characterized by a single polymorphic human VH gene segment, a plurality of human DH 
gene segments and a plurality of JH gene segments. Methods for making antibody 
sequences that bind an antigen (e.g., a viral antigen) are provided, comprising immunizing a 
mouse with an antigen of interest, wherein the mouse comprises a single human VH gene 
segment, a plurality of human DH gene segments and a plurality of JH gene segments, at the 
endogenous immunoglobulin heavy chain locus.
Patent AU-2020293568-A1 (AU)
Title: A method for the manufacture of hydraulic binders from water treatment residuals
Inventor: BROOKS STEPHEN
IPC: C04B28/16
Filed: 2020-06-12
Abstract: A method for the manufacture of a high alumina hydraulic binder comprising hydrating a source of aluminium ions with a source of calcium ions in the presence of water to form mineral hydrates and subsequently heating said mineral hydrates to form said high alumina hydraulic binder.
Patent AU-2020308865-A1 (AU)
Title: Reactive dry powdered hemostatic materials comprising a nucleophile and a multifunctional modified polyethylene glycol based crosslinking agent
Inventor: GREENAWALT KEITH
IPC: A61K9/14
Filed: 2020-06-25
Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are described. The compositions may comprise a first component comprising a polyalkylene oxide-based polymer functionalized with electrophilic reactive groups, and a second component that comprises a protein such as albumin and an optional crosslinking initiator — which may be a base or basic salt such as sodium bicarbonate. The compositions may in certain applications act as hemostats when applied in dry powder form to a bleeding wound, whereupon the first component and the second component of the composition crosslink to form a hydrogel.
Patent AU-2020316988-A1 (AU)
Title: Techniques for call authentication
Inventor: RULE JEFFREY
IPC: H04W12/04
Filed: 2020-07-15
Abstract: Various embodiments described herein are directed towards authenticating calls by using one or more keys associated with a specific user. In examples, the user is the sender of a call. In various embodiments, when a call is made, an identifying payload is encrypted using a private key associated with the user. The encrypted identifying payload is appended to the call data stream. The identifying payload may be decrypted with a public key. In embodiments, the identifying payload may be verified. In various embodiments, further authentication methods may be performed by using an object such as a contactless card to provide one or more components of the identifying payload and/or keys. In embodiments, a connection may be made between the sender and the intended recipient of a call based on the verification of the identifying payload.
Patent AU-2020351212-A1 (AU)
Title: Infant chairs
Inventor: ROSENTHAL JARED
IPC: A47D1/00
Filed: 2020-09-18
Abstract: An infant supporting chair including a frame, a seat movably supported on the frame, a unitary tray and a cooperative guidance and latching system. The cooperative guidance and latching system being configured to magnetically pull the unitary tray toward at least one latching position when the unitary tray is in range of the at least one latching position relative to the seat, releasably secure the unitary tray to the seat when the unitary tray is engaged to the at least one latching position, and slidably position the unitary tray relative to the seat when the unitary tray is partially disengaged from the at least one latching position.
Patent AU-2020360426-A1 (AU)
Title: Enhancing patient care via a structured methodology for workflow stratification
Inventor: SRIVATHSA KARTHIK
IPC: G16H40/20
Filed: 2020-10-01
Abstract: A system, device and method are provided for modifying workflows in a hospital environment. The system includes a workflow stratification server configured to receive and analyze event messages from a nurse call system and interface devices. The workflow stratification server determines a current state of the hospital environment and relevant applicable conditions for each event message identified as a trigger event. That way, the workflow stratification server prioritizes the trigger events and provides responses to the trigger events in a manner that takes into account resources in the hospital environment.
Patent AU-2020366365-A1 (AU)
Title: Dosages and uses of ornithine phenylacetate for treating hyperammonemia
Inventor: WANG REARS XIAOFENG
IPC: A61P7/00
Filed: 2020-10-15
Abstract: Embodiments of the present disclosure relate to doses of ornithine phenylacetate for treating or ameliorating hyperammonemia and the methods of administrating the same in a patient with a chronic liver disease, for example, cirrhosis. In some embodiments, the patient also has hepatic encephalopathy as a complication of the liver disease.
Patent AU-2020368972-A1 (AU)
Title: Structured cross-channel packing element with reduced material requirement
Inventor: AUSNER ILJA
IPC: B01J19/32
Filed: 2020-09-28
Abstract: The present invention relates to a structured cross-channel packing element for a column for mass transfer and/or heat exchange between a heavy and a light fluid phase, wherein the structured cross-channel packing element comprises at least two adjacent layers made of expanded metal sheets each comprising openings, which are surrounded and separated from each other by separating elements, wherein at least two of the at least two layers are arranged in the longitudinal direction of the packing element parallel and in touching contact with each other so that an open space extending from one end to the opposite end of the at least two layers is provided between them so that at least one of the heavy and the light fluid phase may flow through it, wherein the ratio between the average width of at least 50% of the separating elements between adjacent openings and the sheet material thickness is at least 15, wherein the ratio between the maximum distance between at least two of the at least two layers measured in the plane being perpendicular of the longitudinal direction and the average width of the separating elements is at least 4, and wherein the ratio between the distance between two openings being in the direction perpendicular to the stretch direction of the expanded metal sheet adjacent to a separating element and the average width of this separating element is for at least 50% of all separating elements 4 to 6.
Patent AU-2020382219-A1 (AU)
Title: Manufacturing process for making T cells expressing chimeric antigen receptors
Inventor: YU HUI
IPC: C07K14/705
Filed: 2020-11-13
Abstract: Aspects of the present disclosure relate to methods for manufacturing genetically engineered T cells expressing a chimeric antigen receptor (CAR) that provide several improvements over conventional manufacturing methods, thereby enabling production of a robust supply of clinically useful CAR T-cell therapies.